Sunday, December 20, 2015

NHI-Imaging Diagnostics of Dental Diseases and Conditions (Caries, Periodontal Disease, Cracked Teeth, and Pulp Vitality) SBIR R43/R44 (PA 12 195)


MY NOTE: This link was  reposted in the last five hours, so I don't know if the deadline for applicants has been expanded or not.
I posted it because, I had not seen it before. 

http://www.usgrants.org/opportunity/imaging-diagnostics-of-dental-diseases-and-conditions-caries-periodontal-disease-cracked-teeth-and-pulp-vitality-sbir-r43r44/4350

The National Institutes of Health in the health sector is offering a public funding opportunity titled "Imaging Diagnostics of Dental Diseases and Conditions (Caries, Periodontal Disease, Cracked Teeth, and Pulp Vitality) SBIR R43/R44" and is now available to receive applicants.
Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.121 Oral Diseases and Disorders Research.
This funding opportunity was created on Jun 4, 2012 and posted on Jun 4, 2012.
Applicants must submit their applications by Apr 5, 2015.
Eligible applicants include: Small businesses.
Full Funding Opportunity Description:
The intent of this SBIR initiative is to accelerate the advanced development and clinical implementation of reliable, reproducible, highly specific and sensitive imaging diagnostic devices for dental caries, periodontal disease, cracked teeth, and pulp vitality.
These new devices must demonstrate superior specificity and sensitivity compared with current diagnostic methods, such as the visual/tactile/radiographic examination for detection of caries, while not increasing health risks for patients.
Approaches that could be explored include, but are not limited to optical coherence tomography (OCT) with or without Raman spectroscopy, MRI image analysis, electrical conductivity measurement (ECM), quantitative laser fluorescence (QLF), alternating current impedance spectroscopy, multi photon imaging, infrared thermography, infrared fluorescence (IR), ultrasound, and terahertz imaging.
The development of novel modalities is also encouraged.

No comments: